Professional Documents
Culture Documents
Junior Year Fall - Biochemistry pfk-1 Assay Formal Report Nov 30
Junior Year Fall - Biochemistry pfk-1 Assay Formal Report Nov 30
Junior Year Fall - Biochemistry pfk-1 Assay Formal Report Nov 30
PFK-1 Assay Using Capillary metabolic disorders and other effects that
Electrophoresis to Analyze Enzyme mutations on this enzyme may have. For
example, a genetic mutation in the PFKM
Inhibition
gene results in Tarui's disease, which is a
Lawson Spence glycogen storage disease where the ability of
30 November 2021
certain cell types to utilize carbohydrates as
CHEM 0336L
a source of energy is impaired. There are
Dr. Rachael Day also important aspects linking PFK’s
Jeremiah Ellison & Allie Gipson function to cancer. One study showed usage
Abstract: for a PFK inhibition test and its “capacity to
This lab experiment is utilized for detect malignant neoplasms irrespective of
analysis of the third step of Glycolysis, the organs in which cancer cells start
which is catalyzed by PFK-1 and converts proliferating.” (Nakamura et. al). PFK-1 is
F-6-P into Fructose-1,6-Bisphosphate in a inhibited by citrate, ATP and ATA via an
rate limiting committed step. This reaction allosteric site. Aurintricarboxylic Acid,
can be monitored using Capillary (ATA) is a trisodium salt that has a function
Electrophoresis. PFK-1 is allosterically as the biological stain 'chrome violet CG.’
upregulated by ADP and AMP but inhibited ATA has also been found to have antiviral
by ATP. This experiment will analyze the activity in vitro against coronaviruses such
enzyme’s function without inhibitor (ATP) as SARS, MERS and SARS-CoV-2 (Liu et.
present, and then compare it with different al 2020).
levels of inhibitor present. Another section The inhibition from ATA prevalence
of these experiments was protein prevents the conversion of F-6-P to F-1,6-
crystallization. Crystallization is one of the BP which in turn, does not consume ATP.
main techniques used to determine the Because of this, this experiment can
structure of a protein. In our experiment visualize the loss of activity of PFK-1 with
many solutions were created to see which various concentrations of inhibitor (ATA)
yielded the best crystals. while keeping the concentration of substrate
and enzyme constant.
Keywords: Enzyme Kinetics, Glycolysis, This inhibition will be analyzed
Inhibition, PFK-1, allosteric, utilizing Michaelis-Menten kinetics and a
Electrophoresis, Protein Crystallization lineweaver-burk plot to also show the
enzyme’s efficiency in the presence of the
Introduction: inhibitor. This analysis will examine the
Phosphofructokinase-1 (PFK1) variables associated with Michaelis-Menten
catalyzes the irreversible conversion of kinetics, for example Vmax and Km, which
Fructose-6-Phosphate (F-6-P) and ATP into show an enzyme's maximum rate and a
Fructose-1,6-Bisphosphate (F-1,6-BP) and pseudo value for the enzyme’s substrate
ADP. Phosphofructokinase is a highly affinity. The Michaelis constant Km is the
regulated enzyme and a branching point of substrate concentration at which the reaction
glycolysis. An analysis of PFK is important rate is at half-maximum, and is an inverse
in understanding Glycolysis, which is an measure of the substrate's affinity for the
important pathway for energy production in enzyme. If there is a small Km, the rate will
most living organisms. approach Vmax more quickly. The value of
Mutations in PFK are also important Km is dependent on both the enzyme and
to examine so that we can better understand the substrate.
Spence 2
Methods:
This section will be an account of the
procedures that took place in the laboratory.
This experiment was conducted in two
different sessions in the span of two weeks.
The first week consisted of the PFK-1 assay
without any inhibitor present. The following
week conducted the same assay but with our
selected inhibitor (ATA) present in different
concentrations. The results from the second
week and first week were recorded after Tested Group - PFK1 with Inhibitor
completing the Capillary Electrophoresis (ATA)
and saved for comparing the enzyme’s The second week repeated similar
activity with the inhibitor to the control steps to the previous week, starting by
group. preparing a solution. This week, one
Control Group - PFK1 (No Inhibition) solution was made and the components,
During this week, several solutions measured in microliters, are listed in the
were made by various groups participating following table.
in the experiment. The solutions were 10mL
in total and contained varying amounts of F6P SAMPLE ATP TOTAL
enzyme, sample buffer, and ATP. The below BUFFER VOL
values are the components of each solution,
measured in microliters. 2500 5000 2500 10000
Bibliography
Day, Rachael. “Biochemistry Lab 0336.” Biochemistry Lecture CHEM 0336L. Biochemistry Lecture
CHEM 0336L, 30 Nov. 2021, Springfield, Missouri - Drury University
Liu, Cynthia, et al. “Research and Development on Therapeutic Agents and Vaccines for COVID-19
and Related Human Coronavirus Diseases.” ACS Central Science, American Chemical Society, 25
Mar. 2020, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094090/.
Nakamura K;Kituta T;Nakamura Y;Nakajima Y;Kobayashi K;Uchida T; “PFK Inhibition Test for
Cancer Detection: Clinical Applications and Mechanisms of PFK Inhibition.” Cancer Detection
and Prevention, U.S. National Library of Medicine, https://pubmed.ncbi.nlm.nih.gov/2952272/.